Cargando…
Rare disease curative care expenditure-financing scheme-health provider–beneficiary group analysis: an empirical study in Sichuan Province, China
BACKGROUND: Rare diseases impose a heavy economic burden on patients’ families and society worldwide. This study used the samples from Sichuan Province in China to estimate the curative care expenditure (CCE) of ten rare diseases, for supporting the prioritization of rare disease health policies. ME...
Autores principales: | Li, Jia, Yang, Lian, Zhang, Yitong, Liao, Hailun, Ma, Yuan, Sun, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548194/ https://www.ncbi.nlm.nih.gov/pubmed/36209113 http://dx.doi.org/10.1186/s13023-022-02524-1 |
Ejemplares similares
-
Maternal Healthcare Financing: Gujarat's Chiranjeevi Scheme and Its Beneficiaries
por: Bhat, Ramesh, et al.
Publicado: (2009) -
Case study of the beneficiary group distribution of curative care expenditure based on SHA 2011 in Xinjiang autonomous region, China
por: Feng, Honghong, et al.
Publicado: (2021) -
MCBS Highlights: Health Expenditures for Medicare Beneficiaries
por: Murray, Lauren A., et al.
Publicado: (1999) -
Predictability of Prescription Drug Expenditures for Medicare Beneficiaries
por: Wrobel, Marian V., et al.
Publicado: (2003) -
Evolution of Public Health Expenditure Financed by the Romanian Social Health Insurance Scheme From 1999 to 2019
por: Radu, Ciprian-Paul, et al.
Publicado: (2021)